Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $2.25 Million - $3.4 Million
40,000 Added 133.33%
70,000 $5.61 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $457,299 - $691,900
10,000 Added 50.0%
30,000 $1.83 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $807,600 - $1.02 Million
20,000 New
20,000 $988,000
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $801,000 - $1.11 Million
30,000 New
30,000 $1.06 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.